These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 32053144

  • 1. The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathy.
    Florea V, Rieger AC, Natsumeda M, Tompkins BA, Banerjee MN, Schulman IH, Premer C, Khan A, Valasaki K, Heidecker B, Mantero A, Balkan W, Mitrani RD, Hare JM.
    Cardiovasc Res; 2020 Nov 01; 116(13):2131-2141. PubMed ID: 32053144
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM.
    J Am Heart Assoc; 2018 Jul 12; 7(14):. PubMed ID: 30005555
    [Abstract] [Full Text] [Related]

  • 3. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
    Hare JM, DiFede DL, Rieger AC, Florea V, Landin AM, El-Khorazaty J, Khan A, Mushtaq M, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Alfonso CE, Valasaki K, Pujol MV, Golpanian S, Ghersin E, Fishman JE, Pattany P, Gomes SA, Delgado C, Miki R, Abuzeid F, Vidro-Casiano M, Premer C, Medina A, Porras V, Hatzistergos KE, Anderson E, Mendizabal A, Mitrani R, Heldman AW.
    J Am Coll Cardiol; 2017 Feb 07; 69(5):526-537. PubMed ID: 27856208
    [Abstract] [Full Text] [Related]

  • 4. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC.
    Circ Res; 2013 Jan 04; 112(1):165-73. PubMed ID: 23065358
    [Abstract] [Full Text] [Related]

  • 5. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
    Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A.
    JAMA; 2012 Dec 12; 308(22):2369-79. PubMed ID: 23117550
    [Abstract] [Full Text] [Related]

  • 6. Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy.
    Rieger AC, Myerburg RJ, Florea V, Tompkins BA, Natsumeda M, Premer C, Khan A, Schulman IH, Vidro-Casiano M, DiFede DL, Heldman AW, Mitrani R, Hare JM.
    EBioMedicine; 2019 Oct 12; 48():377-385. PubMed ID: 31648988
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
    Vrtovec B, Sever M, Jensterle M, Poglajen G, Janez A, Kravos N, Zemljic G, Cukjati M, Cernelc P, Haddad F, Wu JC, Jorde UP.
    Stem Cells Transl Med; 2016 May 12; 5(5):632-8. PubMed ID: 27025690
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
    Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, Tompkins BA, Khan A, Schulman IH, Landin AM, Mushtaq M, Golpanian S, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Valasaki K, Pujol MV, Ghersin E, Miki R, Delgado C, Abuzeid F, Vidro-Casiano M, Saltzman RG, DaFonseca D, Caceres LV, Ramdas KN, Mendizabal A, Heldman AW, Mitrani RD, Hare JM.
    Circ Res; 2017 Nov 10; 121(11):1279-1290. PubMed ID: 28923793
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
    Martino H, Brofman P, Greco O, Bueno R, Bodanese L, Clausell N, Maldonado JA, Mill J, Braile D, Moraes J, Silva S, Bozza A, Santos B, Campos de Carvalho A, Dilated Cardiomyopathy Arm of the MiHeart Study Investigators.
    Eur Heart J; 2015 Nov 07; 36(42):2898-904. PubMed ID: 26392433
    [Abstract] [Full Text] [Related]

  • 13. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy.
    Pincott ES, Ridout D, Brocklesby M, McEwan A, Muthurangu V, Burch M.
    J Heart Lung Transplant; 2017 Aug 07; 36(8):837-844. PubMed ID: 28162930
    [Abstract] [Full Text] [Related]

  • 14. Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial.
    Sant'Anna RT, Fracasso J, Valle FH, Castro I, Nardi NB, Sant'Anna JR, Nesralla IA, Kalil RA.
    Rev Bras Cir Cardiovasc; 2014 Aug 07; 29(3):437-47. PubMed ID: 25372920
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
    Heeger CH, Jaquet K, Thiele H, Zulkarnaen Y, Cuneo A, Haller D, Kivelitz D, Schmidt T, Krause K, Metzner A, Schneider C, Kuck KH, Bergmann MW.
    EuroIntervention; 2012 Oct 07; 8(6):732-42. PubMed ID: 23086792
    [Abstract] [Full Text] [Related]

  • 16. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Oct 07; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 17. The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials.
    Ory J, Saltzman RG, Blachman-Braun R, Dadoun S, DiFede DL, Premer C, Hurwitz B, Hare JM, Ramasamy R.
    J Sex Med; 2020 Apr 07; 17(4):695-701. PubMed ID: 32059936
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S, Rodrigues J, Campelo M, Moura B, Martins E, Macedo F, Silva-Cardoso J, Maciel MJ.
    Int J Cardiovasc Imaging; 2017 May 07; 33(5):605-613. PubMed ID: 28013418
    [Abstract] [Full Text] [Related]

  • 19. A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy.
    Lu Y, Wang Y, Lin M, Zhou J, Wang Z, Jiang M, He B.
    Stem Cell Res Ther; 2016 Dec 09; 7(1):186. PubMed ID: 27938412
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.
    Premer C, Blum A, Bellio MA, Schulman IH, Hurwitz BE, Parker M, Dermarkarian CR, DiFede DL, Balkan W, Khan A, Hare JM.
    EBioMedicine; 2015 May 09; 2(5):467-75. PubMed ID: 26137590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.